David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents

Reviewing COVID-19's impact on social care, in partnership with LaingBuisson.

Recent applications for various “Tom Moore” marks have been a welcome reminder of the positive stories that emerged from lockdown.

The June edition of our Pharmacy Brief

Dental practitioners are looking ahead to the policies and procedures they will need to put in place in light of COVID-19.